RLAY (RLAY) Stock Price & Analysis
RLAY (RLAY) rose 0.16% to USD 19.04 as of September 8, 2026 at 06:21 UTC, according to Nexqual real-time market data.
RLAY last closed at USD 19.04; the session ranged USD 18.68–19.26 on volume of 2,054,847 shares. Market capitalization is —, with a 52-week range of USD 3.87–21.27 (NGM). Source: Nexqual, September 8, 2026 at 06:21 UTC.
Key Statistics (as of September 8, 2026 at 06:21 UTC)
| Price | USD 19.04 |
|---|---|
| Change | ▲ 0.16% (up) |
| Previous Close | USD 19.04 |
| Open | USD 19.04 |
| Day Range | USD 18.68 – 19.26 |
| 52-Week Range | USD 3.87 – 21.27 |
| Volume | 2,054,847 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (RLAY)
Nexqual's technical model rates RLAY "SELL" based on 1 bullish and 4 bearish signals across 128 daily candles, as of September 8, 2026 at 06:21 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 46.29 (neutral) |
| vs SMA50 | Below (USD 19.36) |
| MACD | -0.11 (negative) |
From RLAY's Latest SEC 10-K Filing (filed 2026-02-26)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| KYMR | Kymera Therapeutics, Inc. | USD 117.39 | ▼ 1.05% |
| NRIX | Nurix Therapeutics, Inc. | USD 26.14 | ▲ 1.24% |
| PCVX | Vaxcyte, Inc. | USD 61.16 | ▼ 0.68% |
| RVMD | Revolution Medicines, Inc. | USD 210.02 | ▲ 0.38% |
| LEGN | Legend Biotech Corporation | USD 21.52 | ▼ 1.69% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:21 UTC. This page is informational and not investment advice.